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ABSTRACT 
Background: elderly people due to their physical and mental 
conditions, receive medications with the intention of improving their 
quality of life but it is not always right. Methodology: the objective of 
this observational and descriptive study was to identify potentially 
inappropriate medications in elderly people older than 65 years of Los 
Guidos de Desamparados, San José, Costa Rica; based on the 
application of the Beers-STOPP-START criteria. We visited the home 
of 143 people, 99 (69%) women and 44 (31%) men. Results: 1.319 
cases of medications were found 31.796 units, especially in tablets 
(79%), 70% of people kept them in the bedroom, 71% came from 
Social Security, 612 cases (46,3%) had less than six months of 
permanence at home and 225 (17%) cases got expired date; the cases of medications are to 
treat affections of the cardiovascular (29%), digestive (22%) and skeletal muscle (12%) 
system; 78,64% of the elderly presented polypharmacy (>5 medicines) and 71% had at least 
one potentially inappropriate medication, highlighting furosemide (18 cases), amlodipine (15 
cases), atenolol (14 cases), enalapril (11 cases), irbesartan (6 cases), famotidine (35 cases), 
omeprazole (18 cases), lovastatin (7 cases), metoclopramide (7 cases), hyoscine butyl 
bromide (7 cases), ibuprofen (31 cases), sulindac (12 cases), indomethacin (9 cases), 
fluoxetine (18 cases), amitriptyline (12 cases) and chlorpheniramine (9 cases). Conclusions: 
the particular conditions of the elderly are combined in a negative way with the large number 
of medicines available at home, which can potentially generate adverse reactions or expire at 
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home. Interventions are required for a rational use of medicines that improve the quality of 
life of the elderly.  
 
KEY WORDS: medicine, home, elderly, aging, pharmacoepidemiology.  
 
INTRODUCTION 
The elderly population has been growing in different parts around the world
[1-4]
 and in Costa 
Rica, that amount surpasses the quarter of a million people, although it is expected to 
continue increasing in the years coming.
[5-7]
 
 
Among the diseases reported by the elderly are non-degenerative chronic diseases, among the 
first places are those of the cardiovascular, digestive, respiratory and skeletal muscle systems; 
such as hypertension, diabetes, lung diseases and arthritis; so also, mobility difficulties, basic 
and instrumental functionality; problems with sight and mental illness, among others. Acute 
diseases include respiratory, intestinal and urinary diseases.
[1,2,4,7-12]
 
 
With the increase in age, physiological changes can occur that cause alterations in the 
pharmacodynamics (physiological effects of the drug) and pharmacokinetics (absorption, 
distribution, metabolism and elimination) of the medicines, which exposes elderly people to 
suffer problems related to the use of medications.
[3,7,10,13-21]
 
 
Hence, it is common to find polypharmacy, poly-medication or a greater number of drugs in 
use, which is justified by biological or physical, social, psychological or health system 
factors; some authors consider that polypharmacy is include between five and ten 
medications and more than ten medications is considered an excessive polypharmacy. The 
premise for this greater number of medications is to treat the various chronic diseases; 
however, this leads to an increase in the likelihood of adverse drug reactions (prevalence 
between 5-50%), as well as hypo glycaemia, hypotension, over anticoagulation, renal failure, 
gastrointestinal and hydroelectric disorders.
[1,10-13,19,21-26]
 Therefore, elderly people can often 
use different medications; such as antibiotics, anticoagulants, diuretics, hypoglycemic agents, 
analgesics, anti-inflammatory
[3]
, antidepressants
[27]
 and over the counter medications
[1,21,28]
.  
 
The poly-pathology associated with aging and the greater number of medications can cause 
various interactions: pharmacological, therapeutic and toxic, among which are those of the 
drug-drug type, drug-disease
[19,29]
, drug-food or food-medication
[13-15,30,31]
 or can also cause 
the inappropriate use of medicines
[10,17,19,20,21,32]
, where the risks outweigh the possible 
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benefits, so it may be that there is a prescription when drugs are used that from the clinical 
point of view are not necessary, that there is deprescription or incorrect prescription when 
selecting an inconvenience medication in dose, via and duration or underuse of medications 
because not using the therapy required as recommended.
[2,10,16,33]
 
 
Elderly people can receive medications not suitable for their particular condition (15-70%), 
which is related to greater morbidity, mortality and use of health resources; for this reason, 
there are explicit mechanisms, consensus of experts based on scientific evidence and implicit 
mechanisms by individual professional assessment of each case that allow the identification 
of potentially inappropriate drugs to optimize their use. Among the useful instruments to 
identify these drugs, the following Beers criteria, the Screening Tool of Older Person's 
Prescriptions (STOPP) - Screening Tool to Alert doctors to Right Treatment (START) 
criteria.
[11,17,25,26,29,34-36]
 
 
This is exemplified by mentioning the use of calcium antagonist drugs that aggravate the 
problem of constipation by decreasing intestinal transit; the use of nonsteroidal anti-
inflammatories agents that can affect the control of people with blood pressure disorders
[4]
 or 
cause dyspepsia, burns in the mouth, gastric irritation, ulcers and bleeding, alone or in 
combination with other nonsteroidal anti-inflammatories, anticoagulants, corticosteroids
[22]
 
and therefore, to these are added famotidine to decrease acidity; however, it may have 
peripheral anticholinergic effects, such as dry mouth, constipation, urinary retention, blurred 
vision and central effects, such as confusion, hallucinations and attention deficit, symptoms 
that are also produced by antidepressants
[27]
; medications with actions on the central nervous 
system, especially benzodiazepines alone or in combination with antidepressants, sedative 
antihistamines, antiepileptic and others, which can promote the risk of falls, accidents, 
cognitive and behavioral changes
[13,15,19,21,29,36]
; the use of non-cardio selective beta-blockers 
in chronic obstructive pulmonary disease due to the risk of bronchospasm
[17,37]
, impairment in 
nutrition due to the reduction of soluble and non-soluble fiber, fat-soluble, vitamins of group 
B and minerals; aggravated by calcium antagonist-beta blockers and angiotensin-converting 
enzyme antagonist drugs that cause dysgeusia or changes in taste perception and affect eating 
habits.
[19]
 
 
The need to handle a greater number of medications can affect therapeutic adherence and it is 
originates from various causes and also generates several consequences
[25,38]
; a big number of 
medications in use implies that the management must be better, since this entails a greater 
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number of names, doses, frequencies and precautions. In addition, it also demands the 
presence of an adequate social support network, with the intention of obtaining adequate 
results and reducing the possibility of problems due to medications.
[21,33,39]
 
 
Drug epidemiological studies such as this allow estimating morbidity in the elderly and 
knowing about the rational management of medications
[9]
, so that through this research, 
potentially inappropriate medications were identified in elderly people of Los Guidos de 
Desamparados in San José, Costa Rica; based on the application of Beers criteria and 
STOPP/START criteria. 
 
METHODOLOGY 
This work is part of the research project of the Institute of Health Research INISA of the 
University of Costa Rica entitled " Situation of the Older Adult in Los Guidos, 
Desamparados." 
 
Los Guidos is a marginal urban area with approximately 25.000 inhabitants and is the 13th 
district of Desamparados area in San José, Costa Rica. 
 
The research project was approved by the Bioethics Committee of the University of Costa 
Rica and this observational, descriptive and cross-sectional study was carried out through the 
home review of all medications of elderly people over 65 years of age. 
 
The selection of elderly people was done by systematic random sampling from the voluntary 
acceptance of the person participating in the research project, a quantity was selected for 
convenience in the opinion of the researchers. 
 
Home visits were scheduled and during each visit, elderly people was asked to enter the home 
agreeing to show all medications in this moment. 
 
A data collection template was designed that included the general aspects of elderly people 
(sex, age) and of each medicine, it was considered: name (generic, commercial), number of 
total units of medicines, receipt and expiration´s date, pharmaceutical form, acquisition and 
storage´s place. 
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The average time for data collection in each home was between forty-five and sixty minutes 
and was carried out by students and professionals in Pharmacy at the University of Costa 
Rica. 
The Microsoft Excel Software was used for the descriptive analysis of the data. 
 
RESULTS 
We visited homes of 143 elderly people, 99 (69,2%) women and 44 (30,8%) men, the 
youngest 65 years and the oldest 94 years.  
 
There were 1.319 cases of medications (31.796 units) as shown in Table 1, medications were 
predominant to treat diseases of cardiovascular system (29%), followed by the digestive, 
metabolism (22%) and skeletal muscle (12%) system. 
 
Table 1. Total cases of medications according to Anatomical Therapeutic Chemical 
classification. 
  Classification Total % 
A Digestive system and metabolism 293 22 
B Blood and hematopoietic 58 4 
C Cardiovascular system 378 29 
D Dermatological 79 6 
G Genitourinary system, sexual 5 0,4 
H Systemic hormonal, sexual 64 5 
J Anti-infective agents 25 2 
L Antineoplastic, immunomodulator 3 0,2 
M Skeletal muscle system 154 12 
N Nervous system 116 9 
P Antiparasitic, insecticides 5 0,4 
R Respiratory system 98 7 
S Organs of the senses 28 2 
V Various 13 1 
  Total 1.319 100 
 
We found that 78,64% of elderly people have polypharmacy (> 5 medications) as shown in 
table 2, most had between five and ten medications, only nine people (6,48%) do not use any 
medication.  
 
The pharmaceutical form that predominated were tablets (1.044/79,2%), followed by creams 
(58/4,3%), oral inhaler (53/4,1%), capsules (43/3,3) %), ophthalmic drops (40/3,1%), 
ointments (23/1,7%), injectables (20/1,5%) and others (38/2,8%). 
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The most frequent medications were: lovastatin (70/49%), famotidine (44/31%), 
acetylsalicylic acid (43/30%), hydrochlorothiazide (43/30%), amlodipine (38/27%), enalapril 
( 34/24%), metformin (33/23%), atenolol (30/21%), ibuprofen (21/15%), insulin (20/14%), 
irbesartan (19/13%), omeprazole (19/13%), beclomethasone (18/13%), fluoxetine (18/13%), 
amitriptyline (15/10%) and salbutamol (15/10%). 
 
Table 2. Number of medications according to sex. 
Number of medications Total % Men % Women % 
0 9 6,48 5 3,60 4 2,88 
1-4 21 14,88 7 4,96 14 9,92 
5-10 65 45,68 23 16,16 42 29,52 
11-20 46 31,38 9 6,14 37 25,24 
> 21 2 1,58 0 0 2 1,58 
Total 143 100 44 30,86 99 69,14 
 
Elderly people receive drugs mainly from Social Security (937/71%), while the rest comes 
from other sources, such as purchase over the counter medicines in the private sector or 
donations from relatives (386/29%). 
 
Predominant places use by people to store medicines were bedroom (105 cases / 70%), 
kitchen (30 cases / 20%), dining room (7 cases / 5%), living room (5 cases / 4%) and 
bathroom (2 cases / 1%). 
 
There were 612 (46,3%) cases of medications that had less than six months of stay at home; 
62 (5%) had between six and twelve months; in 616 cases (46,7%), dispensation date was not 
found, this was not visible or the medication was not labeled, so the time of permanence is 
unknown; 29 (2,1%) cases were more than twelve months at home. The lowest number of 
days of a medication at home was 2 days and the highest was 2,7 years. 
 
As table 3 shows, 225 (17%) cases of medicines were expired, and there were 41 (3%) cases 
of medications at home, which were six months expired and 33 (14.6%) more than twelve 
months; in 133 (59,1%) cases, the expiration date was not found. The expired medication 
with the longest period of stay at home was 7,7 years. 
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Table 3. Days at home of expired medicines, n = 1.319. 
Days Months Cases % 
< 180 < 6 41 18,2 
181-360 6-12 18 8,1 
> 360 > 12 33 14,6 
Unknown Unknown 133 59,1 
Total --- 225 100 
Table 4 shows potentially inappropriate medications according to Beers criteria and 
STOPP/START criteria. 
 
We found that 102 (71%) elderly people had at least one potentially inappropriate 
medication. 
 
Table 4. Potentially inadequate drugs by therapeutic groups according to Beers criteria 
and STOPP/START criteria. 
Therapeutic group Medicines cases 
Antidepressants 
  
Amitriptyline 15 
Imipramine 8 
  
  
Antihistamines 
  
Chlorpheniramine 7 
Dimenhydrinate 7 
Diphenhydramine 7 
Hydroxyzine 4 
Antispasmodics Hyoscyamine and derivatives 9 
  
Anti-infectious 
Nitrofurantoin 1 
Tetracycline 1 
Clarithromycin 1 
Antipsychotic Haloperidol 1 
Central alpha blockers Methyldopa 1 
  
Non-steroidal 
anti-inflammatory 
  
  
Diclofenac 3 
Ibuprofen 21 
Meloxicam 1 
Sulindac 8 
Naproxen 2 
Tenoxicam 3  
Indomethacin 9 
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Therapeutic group Medicines cases 
Benzodiazepines Lorazepam 2 
H2 antagonist Famotidine 46 
Prokinetic Metoclopramide 6 
  
  
Non-steroidal 
anti-inflammatory 
combinations 
Diclofenac + Ibuprofen 1 
Ibuprofen + Sulindac 1 
Acetylsalicylic acid + Ibuprofen 6 
Acetylsalicylic acid + Diclofenaco 3 
Acetylsalicylic acid + Indomethacin 2 
Diclofenac + Sulindac 1 
Indomethacin + Ibuprofen 1 
Indomethacin + Sulindac 1 
Acetylsalicylic acid + Sulindac 1 
Diclofenac + Indomethacin 3 
Diuretic loops Hydrochlorothiazide + Furosemide 1 
  
Antihypertensive 
+ Non-steroidal anti-inflammatory 
Irbesartan + Amlodipine + Atenolol + 
Carvedilol + Sulindac + Ibuprofen 
1 
Irbesartan + Amlodipine + Acetylsalicylic 
acid + Ibuprofen 
2 
Irbesartan + Amlodipine + Diclofenac 1 
Irbesartan + Amlodipine + Naproxen 1 
Amlodipine + Acetylsalicylic acid 8 
Amlodipine + Indomethacin +Tenoxicam 1 
Amlodipine + Ibuprofen 2 
Amlodipine + Sulindac 1 
Amlodipine + Sulindac + 
Ibuprofen + Acetylsalicylic acid 
1 
Irbesartan + Atenolol + 
Acetylsalicylic acid 
3 
Atenolol + Indomethacin 1 
Atenolol + Tenoxicam 1 
Enalapril + Atenolol + Ibuprofen 2 
Irbesartan + Acetylsalicylic acid 2 
Atenolol + Irbesartan + Ibuprofen + 
Acetylsalicylic acid 
1 
Enalapril + Amlodipine + Ibuprofen 1 
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Therapeutic group Medicines cases 
Enalapril + Amlodipine + Tenoxicam 1 
Non-steroidal anti-inflammatory 
+ Antacid 
Sulindac + Aluminum Magnesium 
hydroxide 
1 
Beta-blocker + calcium channel  
Propranolol + Carvedilol + 
 
1 
blocker Verapamil    1 
Beta blocker + 
Oral corticosteroid 
Atenolol + Beclomethasone 2 
Beta-blocker + Antacid Atenolol + Aluminum hidroxide 1 
Beta-blocker + Loop diuretic 
  
Carvedilol + Furosemide 3 
Atenolol + Furosemide 1 
Calcium channel blocker + 
Diuretic loop 
Amlodipine + Furosemide 
2 
  
Non-steroidal anti-inflammatory + 
Loop diuretic 
Acetylsalicylic acid + Furosemide 5 
Ibuprofen + Furosemide 2 
Digitalic + Loop diuretic Digoxin + Furosemide 1 
Aldosterone Antagonist + 
Angiotensin converting enzyme 
inhibitor + Angiotensin antagonist 
Spironolactone + Enalapril + Irbesartan 1 
Spironolactone + Irbesartan 3 
Spironolactone + Enalapril 3 
Aldosterone antagonist + Non-
steroidal anti-inflammatory 
Spironolactone + Acetylsalicylic acid 4 
Aldosterone antagonist + 
Loop diuretic 
Spironolactone + Furosemide 3 
Antipsychotic + Antihypertensive Haloperidol + Irbesartan + Amlodipine 1  
  
  
  
Two antimuscarinics 
/ 
anticholinergic 
  
Hyoscine butyl bromide + 
Diphenhydramine 
1 
Hyoscine butyl bromide + 
Chlorpheniramine + Hydroxyzine + 
Loratadine 
1 
Hydroxyzine + Dimenhydrinate 1 
Hydroxyzine + Diphenhydramine 1 
Ipratropium bromide + Hydroxyzine + 
Loratadine + Cetirizine 
1 
Ipratropium bromide + Cetirizine 1 
Chlorpheniramine + Amitriptyline 1 
Hyoscine butyl bromide + Amitriptyline 4 
Dimenhydrinate + Diphenhydramine 1 
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Therapeutic group Medicines cases 
Tricyclic antidepressant + 
H2 Antagonist 
Amitriptyline + Famotidine 1 
Tricyclic antidepressant + 
Prokinetic 
  
Amitriptyline + Metoclopramide 1 
Imipramine + Metoclopramide 1 
Antihistaminic + Prokinetic 
  
Diphenhydramine + Metoclopramide 1 
Chlorpheniramine + Metoclopramide 1 
Antiespasmódico + Prokinetic 
Hyoscine butyl bromide + 
Metoclopramide 
1 
Benzodiazepine + Antihistamine + 
Antidepressant 
Lorazepam + Chlorpheniramine + 
Fluoxetine 
1 
Antihistamine + Antidepressant Chlorpheniramine + Fluoxetine 5 
Benzodiazepine + Antihistamine + 
Anticonvulsant 
Lorazepam + Diphenhydramine + 
Carbamazepine 
1 
H1 Antagonist + H2Antagonist Diphenhydramine + Famotidine 1 
Prokinetic + Antihistamine 
  
Metoclopramide + Hydroxyzine + 
Loratadine 
2 
Antacid + Oral iron salts 
  
Omeprazole + Fumarate iron 2 
Aluminum -Magnesium -Simethicone + 
Fumarate iron 
3 
H2 antagonist+ Antacid Famotidine + Aluminum hydroxide 2 
  
Antacid combination 
  
Omeprazole + Famotidine + Aluminum -
Magnesium -Simethicone + Magnesium 
Hydroxide 
1 
Omeprazole + Aluminum Hydroxide 1 
Omeprazole + Aluminum -Magnesium -
Simethicone + Magnesium Hydroxide 
2 
Omeprazole + Famotidine 2 
Antiaggregant + Antacid 
Acetylsalicylic acid + Aluminum-
Magnesium-plus simethicone 
1 
Two antidepressants Fluoxetine + Amitriptyline 1 
  
Calcium antagonist + constipation 
treatment 
Amlodipine + Psyllium plantago 1 
Amlodipine + Mineral oil 1 
Calcium antagonist + constipating 
Amlodipine + Acetaminophen with 
codeine 
1 
  
Two anticonvulsants 
  
Carbamazepine + Divalproex sodium 1 
Phenytoin + Divalproex sodium 1 
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Therapeutic group Medicines cases 
Anticonvulsant + Antidepressant Carbamazepine + Amitriptyline 1 
Alpha 2 agonist + antidepressant Methyldopa + Amitriptyline 1 
Anticonvulsant + Opioid Carbamazepine + Tramadol 1 
Anticonvulsant + Selective 
inhibitor recapture serotonin 
Phenytoin + Fluoxetine 1 
Divalproex sodium + Fluoxetine 1 
Anticonvulsant + Proton Pump 
Inhibitor 
Carbamazepine + Omeprazole 
  
1 
Anticonvulsant + Statin Carbamazepine + Lovastatin 2 
Antacid + Statin 
  
Aluminum -Magnesium -Simethicone + 
Lovastatin 
2 
Antiarrhythmic + Statin Amiodarone + Lovastatin 1 
Opioid + Selective inhibitor 
recapture serotonin 
Tramadol + Fluoxetine 1 
Non-steroidal anti-inflammatory + 
Selective inhibitor recapture 
serotonin 
Acetylsalicylic acid + Fluoxetine 3 
Vitamin + Antacid 
Vitamin D + Aluminum -Magnesium -
Simethicone 
1 
Non-steroidal anti-inflammatory + 
antidepressant 
Sulindac + Fluoxetine 
  
1 
hypoglycaemic 
+ Non-steroidal anti-inflammatory 
  
Glibenclamide + Ibuprofen 6 
Glibenclamide + Sulindac 2 
Hypoglycaemic +Anticonvulsant Glibenclamide + Carbamazepine 1 
Hypoglycaemic 
+Loop diuretic 
Metformin + Furosemide 1 
Insulin + Furosemide 1 
Hypoglycaemic 
+ Beta blocker 
Glibenclamide + Enalapril 2 
Metformin + Atenolol 1 
Calcium channel blocker + 
Anticonvulsant 
Amlodipine + Carbamazepine 2 
Two hypoglycaemic Insulin + Glibenclamide 1 
Hypoglycaemic + Thyroid agent Insulin + Levothyroxine 1 
Beta-blocker + insulin Atenolol + Insulin 1 
Beta-blocker + calcium channels 
antagonist 
Propranolol + Carvedilol + Verapamil 
  
1 
Loop diuretic + Anti drop Hydrochlorothiazide + Allopurinol 2 
ACE inhibitor + Anti drop Enalapril + Allopurinol 1 
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Therapeutic group Medicines cases 
ACE inhibitors + Antacid 
  
Enalapril + Aluminum + Magnesium + 
Simethicone 
2 
Antibiotic + Anti drop Amoxicillin + Allopurinol 1 
Antibiotics + ions Tetracycline + Calcium + Aluminum 1 
Antibiotic + Proton Pump Inhibitor Clarithromycin + Omeprazole 2 
Non-steroidal anti inflammatory + 
Proton Pum Inhibitor 
Acetylsalicylic acid + Omeprazole 4 
Antiplatelet agent 
+ Antibiotic 
Clopidogrel + Tetracycline 1 
Antiplatelet agent 
+ Proton Pump Inhibitor 
Clopidogrel + Omeprazole 1 
Antidepressant 
+ Proton Pump Inhibitor 
Fluoxetine + Omeprazole 2 
Cholesterol-lowering agent 
+ Antifungal 
Lovastatin + Itraconazole 1 
Lovastatin + Fluconazole 1 
  
Cholesterol-lowering 
agent+ Antidepressant 
Gemfibrozil + Fluoxetine 1 
Gemfibrozil + Imipramine 2 
Thiazide diuretic + Antifungal Hydrochlorothiazide + Fluconazole 1 
Antidepressant + Ocular beta 
blocker 
Amitriptyline + Timolol 1 
  
Non-steroidal anti-inflammatory 
without H2 antagonist or 
Proton Pump Inhibitor 
Ibuprofen + Acetylsalicylic Acid 3 
Naproxen 1 
Sulindac 1 
Non-steroidal anti-
inflammatory + Corticosteroid 
Acetylsalicylic Acid + Beclomethasone 1 
Thyroid agent + Cholesterol-
lowering agent 
Levothyroxine + lovastatin 
  
3 
Thyroid agent + Iron salts Levothyroxine + Iron 2 
Thyroid agent + Anticonvulsivante Levothyroxine+ Phenytoin 1 
Bisphosphonate 
+Non-steroidal anti-inflammatory 
Alendronate 
+ Acetylsalicylic acid 
2 
Loop diuretic + Non-steroidal anti-
inflammatory 
Furosemide + Ibuprofen + Diclofenac 1 
Antibiotics 
  
Clarithromycin + Amoxicillin + 
Cephalexin 
1 
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We found 388 (29%) cases of potentially inappropriate medications: a) 119 (9%) 
Cardiovascular system, including furosemide (18 cases), amlodipine (15 cases), atenolol (14 
cases), enalapril (11 cases), irbesartan (6 cases); b) 108 (8%) Digestive system, including 
famotidine (35 cases), omeprazole (18 cases), lovastatin (7 cases), metoclopramide (7 cases), 
hyoscine butylbromide (7 cases); c) 66 (5%) Skeletal muscle, such as ibuprofen (31 cases), 
sulindac (12 cases) and indomethacin (9 cases); d) 49 (4%) Nervous system, highlighting 
fluoxetine (18 cases) and amitriptyline (12 cases) and e) 17 (1%) Respiratory system, 
highlights chlorpheniramine (9 cases). 
 
DISCUSSION 
With this study, it was found that 93,5% of elderly people of Los Guidos - Costa Rica, had 
cases of drugs to treat mainly cardiovascular (29%), digestive (22%), skeletal muscle (12%), 
nervous (9%) and respiratory (7%) system. These findings are related to the following results 
found in one study: cardiovascular (22,81%) antimicrobials (16,8%) and gastrointestinal 
system (13,6%)
[28]
; nervous system (35,6%), gastrointestinal (24,4%), cardiovascular 
(23,9%), blood (3,1%), respiratory (3%), skeletal muscle (2,5%)
[40]
 and nervous system 
(25,4%), cardiovascular (25,2%), gastrointestinal (17,1%), respiratory (7,7) in another 
study.
[41]
 
 
Among the medications most consumed by elderly people in Los Guidos - Costa Rica, are 
those to treat hypertension, such as amlodipine (27%), enalapril (24%), atenolol (21%), 
irbesartan (13%); for diabetes, metformin (23%) and insulin (14%); for cholesterol, lovastatin 
(49%), in the case of gastrointestinal disorders, omeprazole (13%) and famotidine (31%); for 
depression, fluoxetine (13%) and amitriptyline (10%); for pain or inflammation such as 
ibuprofen (15%). 
 
These findings agree with a study in which they reported that the drugs most consumed in 
Costa Rica by elderly people were antihypertensive drugs (18%), anti-thrombolytic drugs 
(11%), diuretics (8%), hypoglycemic drugs (7%) and lipid-lowering drugs (6 %)
[42]
; 
similarly, in another study they reported antihypertensives (87%), platelet antiaggregant 
(36%) and they found as potentially inappropriate prescriptions 24%, included diuretics 
(25%), statins (20%), hypoglycemic (18%), non-steroidal anti-inflammatory (9%) and 
antidepressants (4%)
[29]
. 
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In our study, from elderly people with medication, 45,64% had polypharmacy (5-10) and 
31,38% had high polypharmacy (> 10); this result is similar to that reported in the scientific 
literature, so in one study they found polypharmacy in 52% and high polypharmacy in 
23,25%
[28]
, while in another study, they also found 45% of polypharmacy
[43]
 and 75,4% in 
another
[44]
; however, these reports are higher than 24,4% reported in one study (> 5)
[45]
, 
27,4% in another
[29]
 and 6% in the last one.
[46]
 
 
It was found in this study that few people had no medication (6%), 15% had between 1 and 4, 
while the rest had a large number of medications; these results contrast with what was 
reported in a study where the percentage decreases as the number of medications increases, 
namely: 0 (42%), 1-4 (36%), 5-9 (15%), 10-14 (4%),> 15 (1%).
[41]
 
 
In our study, due to the fact that the largest number of drug cases was found in women, there 
were also more women than men reporting polypharmacy; which agrees with that reported in 
a study where the frequency of women was higher (29,6%) than in men (19,2%)
[45]
 and in 
another study, 75,6% was found in women and 59, 3% in men
[47]
 However, these data 
contrast with the report of a study that indicates that the proportion of men with 
polypharmacy was 60,03%.
[28]
 The greater the quantity of drugs present, the likelihood of 
drug-related problems also increases
[26]
, among which the potential interactions stand out, our 
results agree with the reports of other studies. In our study, it was found that 102 elderly 
people (71%) had at least one drug with the potential to be inadequate, a fact that agrees with 
the other study.
[48]
 
 
We found 388 (29%) cases potentially inappropriate medications, cardiovascular system 
(9%), digestive (8%) and skeletal muscle (5%) medicines stood out; in one study, they found 
that 58,2% of elderly people had potentially inappropriate medications and where the nervous 
system (58,7%), anticholinergic (21,2%) and cardiovascular (10,8%) drugs stood out
[49]
; in 
another they found 27% of drugs, especially for nervous system
[46]
 and in another it was 
found that 82 of 467 elderly people had five or more medicines with potential to cause 
adverse reactions, including long-term non-steroidal anti-inflammatory agents, long-acting 
benzodiazepines, anticholinergics, tricyclic antidepressants, metoclopramide
[43]
; in another 
study was detected 6,9% of potentially inappropriate medications
[29]
; in another, they 
reported 27,1%
[46]
; in one more study, it was found that there was a 30,6% potential for 
interactions between central nervous system drugs
[50]
 and in another study, it was reported 
that 82,6% took at least one potentially inappropriate medication, where antipsychotics 
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(26,5%) and analgesics (15,1%) stood out, also highlighting that 29,7% were medicines that 
elderly people should avoid regardless of their condition, 1,1% in certain diseases or 
syndromes and 1,6% of use with caution
[40]
; another study mentions that 20% had non-
steroidal anti-inflammatory, glibenclamide and insulin, in addition one third with constipation 
used calcium antagonists
[51]
, non-steroidal anti-inflammatory in hypertensive patients or with 
acid peptic disease when it has been reported as risky and beta blockers can alter ventilatory 
dynamics
[4]
 
 
We found people using haloperidol, which can cause extrapyramidal effects and can also 
cause variations in blood pressure; however, a case was found where person had the 
combination of several drugs with anticholinergic effects, such as ipratropium, hyoscine butyl 
bromide, cetirizine, hydroxyzine, famotidine, amitriptyline and loratadine; although this 
combination of drugs can inhibit the therapeutic response of haloperidol and, at the same 
time, those drugs can exacerbate the anticholinergic effects (19), even though, there are those 
who justify the use of some of these drugs, since it has been described that anticholinergic 
drugs are used to counteract extrapyramidal effects of antipsychotics.
[37]
 
 
Another aspect is the use of tricyclic antidepressants (amitriptyline) in combination with 
drugs to treat glaucoma but it can exacerbate ocular involvement (37); if person also uses a 
non-steroidal anti-inflammatory agent as ibuprofen and some antihistamines together as 
hydroxyzine and dimenhydrinate, this makes the effect of timolol decrease, so it must resort 
to the need to combine timolol with dorzolamide, an inhibitor of carbonic anhydrase to try to 
control the intraocular pressure.
[37]
 Antidepressants as amitriptyline and imipramine although 
are not totally contraindicated in older adults, but it is known that their anticholinergic effects 
can cause or aggravate constipation like other medicines such as furosemide, levothyroxine 
sodium, and ibuprofen.
[51,52]
 
 
Likewise, a case of amitriptyline use was found in a person with depression, which uses 
metoclopramide and it can cause depression, in addition, that person has the benzodiazepine 
of lorazepam and an antihistamine, chlorpheniramine; what exposes the person at risk of falls 
and anticholinergic effects can antagonizes metoclopramide´s effect.
[37]
 In another case, one 
person also uses metoclopramide which can cause extrapyramidal symptoms and these can be 
accentuated by some antihistamines as loratadine and hydroxyzine, but they may have 
anticholinergic effects
[37]
; in addition, hydroxyzine can cause sleep disturbances.
[17]
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A person had tramadol, an opioid derivative in conjunction with fluoxetine, a selective 
serotonin reuptake inhibitor, this combination generates risk because long-term fluoxetine 
can raise cholesterol and the opioid can aggravate depression and cause seizures, that was 
why, this person maybe receive divalproex sodium; however, the person uses indomethacin 
and acetylsalicylic acid, those can affect kidney function and affect the opiate elimination
[37]
; 
the use of non-steroidal anti-inflammatory leads to the use of omeprazole, a potentially 
inappropriate prescriptions that can also cause seizures and is metabolized via the liver by 
altering the bioavailability of other drugs, such as lovastatin, levothyroxine and fluoxetine. 
 
That person also uses insulin and metformin, but also enalapril and atenolol and nonselective 
beta-blockers can cause hypoglycemia and mask signs / symptoms of hypoglycemia of 
salicylates and metformin. This elderly person uses lovastatin to lower cholesterol, perhaps 
by the use of fluoxetine, but the statin can cause seizures and neuromuscular reactions, such 
as pain, weakness and spasms, also uses levothyroxine which can also cause muscle pain and 
tremor; but its absorption may be diminished by antacids as aluminum hydroxide, magnesium 
hydroxide, every one alone plus combination with simethicone or by iron salts or by the 
effect of phenytoin.
[27,37]
 
 
Other possible interactions between drugs found in this study, it is mentioned that serum 
phenytoin concentrations may increase in the presence of fluoxetine; thiazide diuretics 
together with allopurinol can exacerbate gout
[37]
; the use of alendronate with acetylsalicylic 
acid may have a risk of gastrointestinal adverse effects, especially in conjunction with other 
medications that may favor these disorders such as lovastatin and levothyroxine
[37]
; 
potassium-sparing diuretics such as spironolactone and angiotensin converting enzyme 
inhibitors may cause hyperkalemia risk when combined with irbesartan; amoxicillin, 
angiotensin converting enzyme inhibitors and thiazide diuretics may promote the 
hypersensitivity of allopurinol; hydrochlorothiazide may increase plasma levels of 
fluconazole; furosemide may increase the effects of verapamil, atenolol, and metformin, and 
potentiate the hypotensive and renal effects of non-steroidal anti-inflammatory and 
angiotensin converting enzyme inhibitors by hypovolemia, but metformin may decrease 
furosemide concentrations; furosemide may also increase the risk of toxicity with digitalis 
due to hypokalemia and cause fatigue.
[50,53] 
 
Metformin in conjunction with calcium channel blockers tends to produce hyperglycemia; the 
use of itraconazole is contraindicated with lovastatin due to the enzymatic inhibition that 
www.wjpps.com                               Vol 7, Issue 8, 2018. 
 
 
17 
Norma et al.                                  World Journal of Pharmacy and Pharmaceutical Sciences 
elevates its serum levels; propranolol and carvedilol increase the effect of verapamil which 
can cause bradycardia; high concentrations of clopidogrel could interfere with the 
metabolism of irbesartan and some non-steroidal anti-inflammatory agents, which would 
generate toxicity, some medicines can cause delirium, such as famotidine, amitriptyline, 
diphenhydramine, non-steroidal anti-inflammatory agents; some drugs cause alterations at the 
enzymatic level of cytochrome P450 in the liver, which affects the metabolism of other drugs, 
such as omeprazole and clopidogrel
[50,54]
, tramadol and omeprazole, fluoxetine with 
amitriptyline, carbamazepine and omeprazole, anticonvulsants and fluoxetine, clarithromycin 
and calcium channel blockers
[55]
, risk of hip fracture has been reported in omeprazole users 
for a short period of time.
[47]
 
 
The use of furosemide, levothyroxine and ibuprofen has been associated with constipation; 
which can be aggravated by the use of medications with anticholinergic properties.
[56]
 
Carbazepine has been associated with diarrhea.
[51]
 In case of hypertensive people, the damage 
caused by non-steroidal anti-inflammatory agents include acute renal failure and angiotensin-
converting enzyme inhibitors, angiotensin receptor blockers and diuretics is mentioned
[57]
; 
hypotension is also reported due to the combination of angiotensin converting enzyme 
inhibitors, loop diuretics and calcium channel blockers.
[43]
 
 
In addition, interactions between medications are possible
[14,50,58]
, but this study shows the 
lack of therapeutic adherence by elderly people
[38,39,48,59]
, since half of them had cases of 
medication in their homes for more than six months, which is long time to store them at 
home, although most of them stored in the bedroom (70%), some of them were stored an 
inconvenience place, such as kitchen (too hot) and bathroom (high humidity); besides, 
seventeen percent had reached their expiration date and a significant percentage of older 
people buy over-the-counter medications or receive them through donations from others. 
 
In Costa Rica, a previous study found that people acquire medicines from the Social Security 
and accumulate them at home, even if they have reached their expiration date.
[59,60]
 These 
data agree with another study in which they found that 93% of the people keep the medicines 
in the bedroom and that 50% keep them even if they are expired
[61]
; a contrary situation is 
reported in other places, where they found that 9% of people used to stored expired 
medicines.
[48,62-65]
 Other risk conditions to consider are the use of over-the-counter 
medications
[66-68]
, which aggravate polypharmacy and drugs that are potentially 
inappropriate; however, this is reported as a common practice among older adults, both in 
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Costa Rica
[59]
 and in other countries.
[66-68]
 In addition, it is important to always remind that 
possible interactions between medications and foods should be considered.
[31]
 
 
As a limitation of this study, we have the fact that it cannot be guaranteed that elderly people 
were using all medicines
[9]
 that were present at home; however, the conditions in which these 
drugs were found, make them a latent risk
[68]
, which requires a better team work of health 
professionals and the social support network
[61]
 to minimize all kind of negative impact of 
medications
[15,38]
 on quality of life of the elderly population. 
CONCLUSIONS 
This study demonstrates the potential for adverse reactions due to potentially inappropriate 
medications present at elderly people homes. The medications at home are mainly delivered 
to the Social Security and specially to treat diseases of cardiovascular, digestive and skeletal 
muscle system. The large number of medicines present is consistent with the definition of 
polypharmacy and favor possible drug interactions; in addition, older people accumulate a 
large number of drugs for a long time, which means that some of them reach the expiration 
date. Adequate interventions are needed to help older adults make rational use of medicines 
improving their quality of life. 
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